Komori
Results4107ISE CHEMICALS CORPORATIONMaterials and Chemicals

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

Revenue for the cumulative third quarter period decreased 2.0% year on year, while operating profit decreased 15.2%, resulting in lower revenue and profit. Lower sales volumes of iodine products and increases in personnel expenses, depreciation and amortization, and raw material and fuel prices weighed on profit, but the full-year earnings forecast and dividend forecast were left unchanged.

Worth reading
42Recurring
Scored from 5 of 6 sections
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-15.2
Year-on-year change in operating income (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 January 2026 to 30 September 2026ConsolidatedJapanese GAAP
Net Sales29,440¥ millionYear on year -2.0%Progress 77.5%
Operating profit6,362¥ millionYear on year -15.2%Progress 79.5%
Ordinary income6,247¥ millionYear on year -14.6%Progress 80.1%
Net income attributable to owners of the parent4,352¥ millionYear on year -16.0%Progress 80.6%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥85.41
Financial position at period-end
Total assets51,382¥ million
of which net assets 42,396 ¥ millionEquity ratio 82.5%vs. prior year-end +4.0pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueIodine and Natural Gas Business ¥25,509 million (YoY -3.8%), Metal Compounds Business ¥3,931 million (YoY +11.8%)
Segment profitIodine and Natural Gas Business ¥6,344 million (YoY -15.1%), Metal Compounds Business ¥18 million (YoY -36.9%)
Regional sales¥12,964 million, ¥8,279 million, ¥3,062 million, ¥5,133 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥38,000 million (YoY -3.2%)
Operating profit¥8,000 million (YoY -15.7%)
Ordinary income¥7,800 million (YoY -15.7%)
Net income¥5,400 million (YoY -16.9%)
Annual Dividend Forecast¥390.00 (actual for the fiscal year ended December 2025, before the stock split) → ¥40.00 (forecast for the fiscal year ending December 2026)(+2.6% (calculated))
Factors Behind Changes in Business Performance

Net sales and income fell below the year-earlier period due to lower sales volumes of iodine products to certain customers, increased personnel expenses and depreciation associated with proactive capital investment, and higher raw material and fuel prices, among other factors.

Disclosure regarding the going concern assumption

None

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name Not applicable
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of non-current assets ¥39 million, Other ¥4 million, Total extraordinary losses ¥43 million
Depreciation and amortization¥1,842 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者:Not disclosed)
Issued Shares at Period-End51,351,350 shares
Treasury Shares at Period-End393,580 shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026 to 30 September 2026
Net Sales¥29,440 million (YoY -2.0%)
Operating profit¥6,362 million (YoY -15.2%)
Ordinary income¥6,247 million (YoY -14.6%)
Profit attributable to owners of the parent¥4,352 million (YoY -16.0%)
Net income per share¥85.41
Equity ratioEnd of the current fiscal period 82.5 / End of previous period 78.5
Total assets¥51,382 million
Net assets¥42,396 million
Full-year earnings forecastNet Sales ¥38,000 million (YoY -3.2%) / Operating profit ¥8,000 million (YoY -15.7%) / Ordinary income ¥7,800 million (YoY -15.7%) / Net income ¥5,400 million (YoY -16.9%)
Annual Dividend Forecast¥390.00 (actual for the fiscal year ended December 2025, before the stock split) → ¥40.00 (forecast for the fiscal year ending December 2026)(+2.6% (calculated))
Segment revenueIodine and Natural Gas Business ¥25,509 million (YoY -3.8%), Metal Compounds Business ¥3,931 million (YoY +11.8%)
Segment profitIodine and Natural Gas Business ¥6,344 million (YoY -15.1%), Metal Compounds Business ¥18 million (YoY -36.9%)
Regional sales¥12,964 million, ¥8,279 million, ¥3,062 million, ¥5,133 million
Depreciation and amortization¥1,842 million
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of non-current assets ¥39 million, Other ¥4 million, Total extraordinary losses ¥43 million
Disclosure regarding the going concern assumptionNone
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name Not applicable
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者:Not disclosed)
Issued Shares at Period-End51,351,350 shares
Treasury Shares at Period-End393,580 shares
Factors Behind Changes in Business PerformanceNet sales and income fell below the year-earlier period due to lower sales volumes of iodine products to certain customers, increased personnel expenses and depreciation associated with proactive capital investment, and higher raw material and fuel prices, among other factors.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyOrders received and order backlogImpairment lossMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Lower sales volumes of iodine products to some customers, higher personnel expenses and depreciation and amortization associated with proactive capital investment, and higher raw material and fuel prices.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.